Albany, NY -- (SBWIRE) -- 03/14/2016 -- Transparency Market Research (TMR) has recently published a research report on the global heparin market for , which estimates the market to rise at a CAGR of 6.30% over the period from 2015 to 2023 and reach a value of US$14.3 bn by the end of the forecast period.The market study, titled "Heparin Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023," states that the worldwide heparin market stood at US$8.2 bn in 2014.

Heparin is an injectable blood thinner, utilized for the treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is also employed as part of the treatment of unstable angina and myocardial infarction. The increasing incidence of coagulation disorders is propelling the demand for heparin significantly across the world.

The global heparin market has been analyzed on the basis of product in this research report. Ultra-low molecular weight heparin (ULMWHs), low molecular weight heparin (LMWHs), and unfractionated heparin are the major products available in the worldwide heparin market. ULMWHs has been the most commonly used heparin over the past decade. However, the increasing overall cost of ULMWHs is likely to hamper the growth of this market segment in the near future, states the research report.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803

The report also studies the global heparin market on the basis of its regional spread. According to the study, Europe, North America, Asia Pacific, and the Rest of the World are the prime regional markets for heparin.

Europe dominated the global heparin market in 2014, while North America occupied the second position. The rising incidence of coagulation disorders in North America and Europe is driving these regional markets significantly.

In addition to this, the growing prevalence of deep vein thrombosis (DVT), spurred by the rapid increase in the geriatric population, leading to cancer, heart failure, and obesity is likely to drive the demand for heparin in these regions over the forecast period, notes the research study.

The heparin markets in Asia Pacific and the Rest of the World are also expected to exhibit healthy growth during the forecast period on account of the presence of a largely untapped market. Analysts at TMR anticipate the economic growth, the infrastructural development in the healthcare sector, and the rising number of surgical procedures in these regions to fuel the demand for heparin significantly in the coming years.

Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., LEO Pharma A/S, Fresenius Kabi AG, Mylan N.V., Sanofi S.A., Pfizer Inc., and Syntex S.A. are some of the key participants in the global heparin market profiled in the report.

The global heparin market is segmented into:

By Product

Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)

By Region

North America
United States
Canada
Europe
Germany
United Kingdom
France
Rest of the Europe
Asia Pacific
India
China
Japan
Rest of Asia Pacific
Rest of the World
Latin America
Africa
Other Countries

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/